APA

Laliberté F., Cloutier M., Crivera C., Nelson W. W., Olson W. H., Schein J., Vanderpoel J., Germain G. & Lefebvre P. (20160119). Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. : Clinical therapeutics.

Chicago

Laliberté François, Cloutier Michel, Crivera Concetta, Nelson Winnie W, Olson William H, Schein Jeffrey, Vanderpoel Julie, Germain Guillaume and Lefebvre Patrick. 20160119. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. : Clinical therapeutics.

Harvard

Laliberté F., Cloutier M., Crivera C., Nelson W. W., Olson W. H., Schein J., Vanderpoel J., Germain G. and Lefebvre P. (20160119). Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. : Clinical therapeutics.

MLA

Laliberté François, Cloutier Michel, Crivera Concetta, Nelson Winnie W, Olson William H, Schein Jeffrey, Vanderpoel Julie, Germain Guillaume and Lefebvre Patrick. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. : Clinical therapeutics. 20160119.